{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:23:24Z","timestamp":1779200604140,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","strokejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.027","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T20:33:27Z","timestamp":1536352407000},"page":"2905-2918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta\u00adAnalysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Min","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0001","first-page":"1298","article-title":"Research progress on diagnosis and screening tools of post stroke depression","volume":"31","author":"Li","year":"2017","journal-title":"Nurs Res China"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1192\/bjp.bp.111.107664","article-title":"Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis","volume":"202","author":"Ayerbe","year":"2013","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0003","first-page":"005","article-title":"Post-stroke depression: mechanisms and pharmacological treatment","volume":"11","author":"Villa","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0004","first-page":"395","article-title":"Progress in diagnosis and treatment of post-stroke depression","volume":"9","author":"Li","year":"2010","journal-title":"Chin J Mult Organ Dis Elderly"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0006","first-page":"42","article-title":"A control study of citalopram and sertraline in the treatment of post-stroke depression","volume":"26","author":"Xu","year":"2013","journal-title":"Sichuan Ment Health"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0007","first-page":"29","article-title":"Observation on the effect of citalopram and fluoxetine in the treatment of poststroke depression","volume":"13","author":"Cheng","year":"2010","journal-title":"Chin J Pract Nerv Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0008","first-page":"37","article-title":"Citalopram and fluoxetine in the treatment of post-stroke depression clinical control study","volume":"4","author":"Duan","year":"2010","journal-title":"China Clin Prac Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0009","first-page":"2","article-title":"A control study of citalopram and paroxetine in the treatment of post-stroke depression","volume":"28","author":"Song","year":"2009","journal-title":"Chin Foreign Med Treat"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0010","first-page":"988","article-title":"A control study of citalopram and paroxetine in the treatment of post-stroke depression","volume":"20","author":"Zhang","year":"2008","journal-title":"Med J Chin Peoples Health"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0011","first-page":"223","article-title":"A clinical study of citalopram in the treatment of post-stroke depression","volume":"20","author":"Li","year":"2007","journal-title":"J Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0012","first-page":"266","article-title":"60 clinical control studies of citalopram and fluoxetine in the treatment of post-stroke depression","volume":"18","author":"Yue","year":"2005","journal-title":"Shandong Arch Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0013","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1176\/appi.neuropsych.11110325","article-title":"Duloxetine versus citalopram and sertraline in the treatment of post stroke depression, anxiety, and fatigue","volume":"24","author":"Karaiskos","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0014","first-page":"171","article-title":"Comparative study of venlafaxine sustained-release capsules and citalopram tablets in the treatment of post-stroke depression","volume":"33","author":"Xia","year":"2015","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0015","first-page":"1618","article-title":"Comparison study of duioxetine and citalopram in the treatment of post-stroke comorbid anxiety and depression","volume":"20","author":"Zhang","year":"2012","journal-title":"Chin J Health Psychol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0016","first-page":"135","article-title":"Observation on the effect of citalopram and venlafaxin in the treatment of post-stroke depression","volume":"50","author":"Liu","year":"2012","journal-title":"China Mod Doct"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0017","first-page":"33","article-title":"A comparative study of venlafaxine and citalopram in the treatment of post-stroke depression","volume":"2","author":"Lv","year":"2008","journal-title":"Chin J Mod Drug Appl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0018","first-page":"12","article-title":"Citalopiam versus venlafaxine for the improvement of post-stroke depression","volume":"9","author":"Zhao","year":"2005","journal-title":"Chin J Clin Rehab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0019","first-page":"195","article-title":"Clinical treatment on 100 cases of PSD with citalopram","volume":"6","author":"Feng","year":"2013","journal-title":"China J Pharm Econ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0020","first-page":"546","article-title":"Efficacy and safety of citalopram and sertraline in the treatment of post stroke depression","volume":"10","author":"Li","year":"2012","journal-title":"Guide Chin Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0021","first-page":"97","article-title":"58 cases of citalopram in the treatment of post-stroke depression and neural functional recovery","volume":"6","author":"Zhang","year":"2012","journal-title":"Chin J Mod Drug Appl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0022","first-page":"44","article-title":"A comparative study of citalopram in the treatment of post-stroke depression","volume":"14","author":"Gong","year":"2012","journal-title":"Chin Community Doct"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0023","first-page":"3697","article-title":"A control study of citalopram vs. fluoxetine in the treatment of post-stroke depression","volume":"32","author":"Wei","year":"2011","journal-title":"Jilin Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0024","first-page":"32","article-title":"A control study of citalopram and fluoxetine in the treatment of post-stroke depression","volume":"12","author":"Wang","year":"2008","journal-title":"Chin J Mod Drug"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0025","first-page":"121","article-title":"Comparative study of citalopram in the treatment of post-stroke depression","volume":"17","author":"Jiang","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0026","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0033-3182(09)70857-6","article-title":"Sex differences in the prevalence of post-stroke depression: a systematic review","volume":"50","author":"Poynter","year":"2009","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0027","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejphar.2013.07.014","article-title":"Electrophysiological evidence for rapid 5-HT1A autoreceptor inhibition by vilazodone, a 5-HT1A receptor partial agonist and 5-HT reuptake inhibitor","volume":"714","author":"Ashby","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0028","first-page":"75","article-title":"Another SSRI citalopram","volume":"30","author":"Wang","year":"2003","journal-title":"Foreign Med Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.07.027_bib0029","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000441446","article-title":"Efficacy and safety of citalopram in treating post-stroke depression: a meta-analysis","volume":"74","author":"Tan","year":"2015","journal-title":"Eur Neurol"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718303963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718303963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:39:07Z","timestamp":1760942347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718303963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1052305718303963"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.07.027","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta\u00adAnalysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Stroke and Cerebrovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}